Condensed Consolidated Statement of Changes in Equity (Deficit) (Unaudited) - USD ($) $ in Thousands	Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Treasury Stock, Common [Member]	Noncontrolling Interest [Member]	Total
Beginning balance at Dec. 31, 2021	$ 2,419	$ 86	$ 198,071	$ (138,910)		$ 17,752	$ 79,418
Beginning balance, shares at Dec. 31, 2021	1,113,919	86,367,845
Dividends declared - Series B Convertible Preferred Stock	$ 67			(67)
Dividends declared series B convertible preferred stock, shares	22,291
Vest - restricted stock awards
Vest restricted stock awards, shares		466,666
Purchase - Employee Stock Purchase Plan			217				217
Purchase employee stock purchase plan, shares		194,240
Impact of subsidiary equity transactions			(87)			87
Stock-based compensation - PAVmed Inc.			1,277				1,277
Stock-based compensation - majority-owned subsidiaries						3,537	3,537
Treasury stock					(512)		(512)
Treasury stock, shares		(354,609)
Net Loss				(16,872)		(2,761)	(19,633)
Exercise - Series Z warrants
Exercise series Z warrants, shares		5
Exercise - stock options		$ 1	241				242
Exercise stock options, shares		237,499
Exercise - stock options of majority-owned subsidiary						187	187
Ending balance at Mar. 31, 2022	$ 2,486	$ 87	199,719	(155,849)	(512)	18,802	64,733
Ending balance, shares at Mar. 31, 2022	1,136,210	86,911,646
Beginning balance at Dec. 31, 2021	$ 2,419	$ 86	198,071	(138,910)		17,752	79,418
Beginning balance, shares at Dec. 31, 2021	1,113,919	86,367,845
Ending balance at Dec. 31, 2022	$ 2,695	$ 95	216,106	(228,169)	(408)	20,615	10,934
Ending balance, shares at Dec. 31, 2022	1,205,759	94,510,537
Dividends declared - Series B Convertible Preferred Stock	$ 72			(72)
Dividends declared series B convertible preferred stock, shares	24,128
Issue common stock - PAVM ATM Facility		$ 1	556				557
Issue common stock PAVM ATM facility, shares		1,081,997
Vest - restricted stock awards
Vest restricted stock awards, shares		100,000
Conversions - Senior Secured Convertible Note		$ 5	2,022				2,027
Conversions senior secured convertible note, shares		4,330,643
Purchase - Employee Stock Purchase Plan			122		60		182
Purchase employee stock purchase plan, shares		384,383
Purchase - majority-owned subsidiary common stock - Employee Stock Purchase Plan						276	276
Issuance - majority-owned subsidiary common stock - At-The-Market Facility, net of financing charges						284	284
Impact of subsidiary equity transactions			1,189			(1,189)
Issuance - majority-owned subsidiary common stock - Settlement APA-RDx - Termination Payment						713	713
Issuance - majority-owned subsidiary preferred stock						13,625	13,625
Stock-based compensation - PAVmed Inc.			1,199				1,199
Stock-based compensation - majority-owned subsidiaries			401			2,820	3,221
Treasury stock			(348)		348
Treasury stock, shares		188,846
Net Loss				(17,931)		(4,283)	(22,214)
Ending balance at Mar. 31, 2023	$ 2,767	$ 101	$ 221,247	$ (246,172)		$ 32,861	$ 10,804
Ending balance, shares at Mar. 31, 2023	1,229,887	100,596,406